15 – 17/02/2024

Grand Hyatt Hotel, Athens

IASIS PHARMA participated at the “Seminars of the Cardiology Working Groups”, held in Athens, at the Grand Hyatt Athens Hotel, from February 15 to 17, 2024.

In IASIS PHARMA exhibition stand, the following products were presented:

  • RosuZet®: New Product Launching. Fixed-dose combination of Rosuvastatin & Ezetimibe, in a single dosage form, in packages of  30 f.c. tabs available in the full spectrum of strengths:
    (Rosuvastatin / Ezetimibe)
    – 5 / 10mg
    – 10 /10mg,
    – 20 / 10mg,
    – 40 /10mg.
  • Rami–Amlo®, a fixed-dose combination of Ramipril & Amlodipine in a single dosage form, in packages of 28 capsules, available in 4 strengths:
    – 5mg/5mg,
    – 5mg/10mg,
    – 10mg/5mg,
    – 10mg/10mg.
  • Rami–Amlo plus®, also an original fixed-dose combination of Ramipril – Amlodipine –Hydrochlorothiazide, which is available in packages of 30 capsules, in a wide range of strengths:
    – 5 mg / 5 mg / 12,5 mg,
    – 5 mg / 5 mg / 25 mg,
    – 10 mg / 5 mg / 25 mg,
    – 10 mg / 10 mg / 25 mg
  • Licepler® (Eplerenone), available in packages of 30 film-coated tablets, in 25mg and 50mg strengths.
  • MAG–IASIS®, the first uniquely effective combination of 1193.57 mg Magnesium citrate & 667.56 mg Magnesium aspartate, equivalent to 243 mg Magnesium, indicated for magnesium deficiency, in the form of 40 effervescent tablets.

ΟΜ-ΕΡΓΑΣΙΑΣ_Athens_2024